Compass Pathways Inc.

Compass Pathways Inc. filed a Q3 report for Compass Pathways Inc. on October 20, 2025.

Lobbying for Compass Pathways Inc. · Biotechnology company

As filed: COMPASS PATHWAYS INC. for COMPASS PATHWAYS INC.

All filings by Compass Pathways Inc. · Everything Compass Pathways Inc. has reported

Amended

The filer submitted a later report covering this same period, so the amounts here have been replaced. Site totals count only the latest version. See the current filing, posted Jan 20, 2026.

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2025

July 1 - Sep 30 · Posted Oct 20, 2025

Expenses

$140,000

What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

New York

Official filing document

Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Budget/Appropriations

Discussions regarding legislative and regulatory issues, including appropriations, pertaining to the use and application of psychedelic medicines.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.